Paper36901812
Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method.
Gajewska-Naryniecka A and 5 others. Int J Mol Sci, 2023. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method. Papers, record 36901812. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901812
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Irreversible Electroporation in Pancreatic Cancer-An Evolving Experimental and Clinical Method.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pancreatic Neoplasms | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Combined Modality Therapy | |
| Electroporation | |
| Treatment Outcome |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| IREC project No. 2020/ABM/01/00098/P/02 | Medical Research Agency | PubMed |
Source PubMed
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18415132 | The effect of electroporation pulses on functioning of the heart. | Med Biol Eng Comput | 2008 | https://conductscience.org/library/papers/18415132 | PubMed |
| 2 | 24975085 | Combination of therapy with 5-fluorouracil and cisplatin with electroporation in human ovarian carcinoma model in vitro. | Biomed Pharmacother | 2014 | https://conductscience.org/library/papers/24975085 | PubMed |
| 3 | 26328033 | Irreversible electroporation and the pancreas: What we know and where we are going? | World J Gastrointest Surg | 2015 | https://conductscience.org/library/papers/26328033 | PubMed |
| 4 | 33374223 | Electrochemotherapy with Calcium Chloride and 17β-Estradiol Modulated Viability and Apoptosis Pathway in Human Ovarian Cancer. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/33374223 | PubMed |
| 5 | 26258317 | Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. | Ann Surg | 2015 | https://conductscience.org/library/papers/26258317 | PubMed |
| 6 | 29986632 | Electrochemotherapy as a New Modality in Interventional Oncology: A Review. | Technol Cancer Res Treat | 2018 | https://conductscience.org/library/papers/29986632 | PubMed |
| 7 | 34303953 | New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) - A pilot preclinical study. | Surg Oncol | 2021 | https://conductscience.org/library/papers/34303953 | PubMed |
| 8 | 26874618 | Applications of calcium electroporation to effective apoptosis induction in fibrosarcoma cells and stimulation of normal muscle cells. | Bioelectrochemistry | 2016 | https://conductscience.org/library/papers/26874618 | PubMed |
| 9 | 27393627 | Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma. | J Surg Oncol | 2016 | https://conductscience.org/library/papers/27393627 | PubMed |
| 10 | 28106146 | Asymmetric Waveforms Decrease Lethal Thresholds in High Frequency Irreversible Electroporation Therapies. | Sci Rep | 2017 | https://conductscience.org/library/papers/28106146 | PubMed |
| 11 | 24238374 | Tumor ablation: common modalities and general practices. | Tech Vasc Interv Radiol | 2013 | https://conductscience.org/library/papers/24238374 | PubMed |
| 12 | 35139717 | Irreversible electroporation in renal tumours: A systematic review of safety and early oncological outcomes. | Urologia | 2022 | https://conductscience.org/library/papers/35139717 | PubMed |
| 13 | 26906114 | Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. | Eur J Surg Oncol | 2016 | https://conductscience.org/library/papers/26906114 | PubMed |
| 14 | 33638687 | Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis. | Eur Radiol | 2021 | https://conductscience.org/library/papers/33638687 | PubMed |
| 15 | 22475953 | A brief overview of electroporation pulse strength-duration space: a region where additional intracellular effects are expected. | Bioelectrochemistry | 2012 | https://conductscience.org/library/papers/22475953 | PubMed |
| 16 | 26633834 | Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model. | PLoS One | 2015 | https://conductscience.org/library/papers/26633834 | PubMed |
| 17 | 23177107 | Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. | J Vasc Interv Radiol | 2012 | https://conductscience.org/library/papers/23177107 | PubMed |
| 18 | 29191513 | International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. | Pancreatology | 2018 | https://conductscience.org/library/papers/29191513 | PubMed |
| 19 | 25170201 | Therapeutic options for the management of pancreatic cancer. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25170201 | PubMed |
| 20 | 26622097 | Irreversible Electroporation. | Semin Intervent Radiol | 2015 | https://conductscience.org/library/papers/26622097 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42975837 | Feasibility of real-time 1.5-T MR-guided percutaneous irreversible electroporation in a porcine model. | Eur Radiol Exp | 2026 | https://conductscience.org/library/papers/42975837 | PubMed |
| 42719117 | The electrical tumor microenvironment: abnormalities and opportunities. | Front Oncol | 2026 | https://conductscience.org/library/papers/42719117 | PubMed |
| 42688057 | Does tumor location affect irreversible electroporation outcomes in pancreatic cancer? A head-to-head comparative cohort study. | Front Oncol | 2026 | https://conductscience.org/library/papers/42688057 | PubMed |
| 41991586 | Combination of irreversible and calcium electroporation to overcome heterogeneity-associated incomplete ablation in the pancreas. | Sci Rep | 2026 | https://conductscience.org/library/papers/41991586 | PubMed |
| 41976359 | Systematic Review and Meta-Analysis of Current and Novel Approaches in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41976359 | PubMed |
| 41890743 | Experimental study on synergistic pulses improving the tumor microenvironment and assisting immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/41890743 | PubMed |
| 41047430 | Pancreatic cancer in the era of precision medicine: challenges, advances, and the future of therapeutic strategies. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/41047430 | PubMed |
| 41046199 | Non-Invasive Pancreas Ablation Using Histotripsy: Pre-clinical Safety Study in an In Vivo Porcine Model. | Ultrasound Med Biol | 2026 | https://conductscience.org/library/papers/41046199 | PubMed |
| 40923270 | High-voltage electrical pulses for pancreatic cancer treatment in the era of precision medicine. | Int J Surg | 2026 | https://conductscience.org/library/papers/40923270 | PubMed |
| 40647392 | Endoscopic Immuno-Oncology: A New Frontier in Treatment of Pancreatic Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647392 | PubMed |
| 40108103 | A Soft Spot for Bleeding: Pseudoaneurysm of the Gastroduodenal Artery in a 71-Year-Old Woman Undergoing Electroporation for a Pancreatic Head Cancer. | Dig Dis Sci | 2025 | https://conductscience.org/library/papers/40108103 | PubMed |
| 40076917 | Investigation of the Bystander Effect on Cell Viability After Application of Combined Electroporation-Based Methods. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076917 | PubMed |
| 39898755 | Foundational insights for theranostic applications of magnetoelectric nanoparticles. | Nanoscale Horiz | 2025 | https://conductscience.org/library/papers/39898755 | PubMed |
| 39766257 | Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses. | Biomolecules | 2024 | https://conductscience.org/library/papers/39766257 | PubMed |
| 39712216 | Modulating the Cell Death Immune Response for Electroporation Treatments. | Bioelectricity | 2024 | https://conductscience.org/library/papers/39712216 | PubMed |
| 39658672 | Radiofrequency ablation (RFA) in unresectable pancreatic adenocarcinoma: meta-analysis & systematic review. | Surg Endosc | 2025 | https://conductscience.org/library/papers/39658672 | PubMed |
| 39589586 | Advances in irreversible electroporation for prostate cancer. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39589586 | PubMed |
| 39354834 | Evaluation of cryoablation using a prototype cryoablation needle in swine liver. | Clin Endosc | 2024 | https://conductscience.org/library/papers/39354834 | PubMed |
| 38673901 | The Induction of Combined Hyperthermal Ablation Effect of Irreversible Electroporation with Polydopamine Nanoparticle-Coated Electrodes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38673901 | PubMed |
| 38644713 | Smart Nanobiomaterials for Gene Delivery in Localized Cancer Therapy: An Overview from Emerging Materials and Devices to Clinical Applications. | Curr Cancer Drug Targets | 2025 | https://conductscience.org/library/papers/38644713 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36901812
GET https://conductscience.org/api/papers/v1/36901812/references?page=2